Search

everythinglearnresearchcommunity

for

Search:↓

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Androgen receptors help prostate cancer cells grow and resist drugs.

DHT stops hair regrowth in mice, similar to human hair loss.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Human keratinocytes do not naturally respond to androgens.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

Estrogen and androgen signals control synaptic changes in rat brains.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

New treatments for common hair loss might be safer and more effective than current options.

Increased PPARGC1α relates to hair thinning in common baldness.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.